Jan O'Sullivan (Limerick East, Labour)

I wonder whether that was in order to get around the Competition Act and the difficulties we encountered due to the fact that the HSE could not talk to the IPU. The Minister might provide a reply in this regard.

My other question is to do with reference pricing and generic substitution, a scheme for which was announced by the Minister last week. I am trying to obtain clarity on this. If a GP prescribes a drug that is more expensive than the reference price, who pays the difference for private and public patients?

See this speech in context